The dialysis encephalopathy syndrome. Possible aluminum intoxication.

The aluminum content of muscle, bone and brain was measured in control subjects and in uremic patients on dialysis who had been maintained on phosphate-binding aluminum gels. The mean muscle aluminum was 14.8 ppm, and the trabecular-bone aluminum 98.5 ppm in the patients on dialysis, as compared with 1.2 and 2.4 in control subjects (P less than 0.05). Brain gray-matter aluminum values in a group of uremic patients on dialysis who died of a neurologic syndrome of unknown cause were 25 ppm as compared with 6.5 ppm in a group of uremic patients on dialysis who died of other causes and 2.2 ppm in control subjects. The fact that brain gray-matter aluminum was higher in all patients with the dialysis-associated encephalopathy syndrome than any of the control subjects or other uremic patients on dialysis suggests that this syndrome may be due to aluminum in intoxication.

[1]  J. Holmes,et al.  SYNDROME OF DYSPRAXIA AND MULTIFOCAL SEIZURES ASSOCIATED WITH CHRONIC HEMODIALYSIS , 1972, Transactions - American Society for Artificial Internal Organs.

[2]  M. Evenson,et al.  Determination of serum copper by atomic absorption, with use of the graphite cuvette. , 1975, Clinical chemistry.

[3]  G. Berlyne,et al.  Hyperaluminaemia from aluminum resins in renal failure. , 1970, Lancet.

[4]  J. Lawrence,et al.  Dialysis-associated dementia. , 1975, Australian and New Zealand journal of medicine.

[5]  C. Ogg,et al.  Aluminium in Bone from Patients with Renal Failure , 1971, British medical journal.

[6]  I. H. Tipton,et al.  TRACE ELEMENTS IN HUMAN TISSUE. PART II. ADULT SUBJECTS FROM THE UNITED STATES , 1963 .

[7]  H. Wiśniewski,et al.  EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION: 1. LIGHT MICROSCOPIC OBSERVATIONS , 1965, Journal of neuropathology and experimental neurology.

[8]  D. Crapper,et al.  Brain Aluminum Distribution in Alzheimer's Disease and Experimental Neurofibrillary Degeneration , 1973, Science.

[9]  E. Quellhorst,et al.  Aluminium-bestimmung im serum mit flammenloser atomabsorption , 1974 .

[10]  E. F. Perry,et al.  Determination of cadmium in blood and urine by graphite furnace atomic absorption spectrophotometry. , 1975, Clinical chemistry.

[11]  S. Massry,et al.  Renal Osteodystrophy: Some Therapeutic Considerations Relative to Long-Term Dialysis and Transplantation , 1969 .

[12]  E. Levine,et al.  EFFECTS OF ALUMINUM SALTS ON CULTURED NEUROBLASTOMA CELLS , 1974, Journal of neurochemistry.

[13]  J. Eastwood,et al.  The effect of aluminium hydroxide on calcium, phosphorus and aluminium balances, the serum parathyroid hormone concentration and the aluminium content of bone in patients with chronic renal failure. , 1972, Clinical science.

[14]  N. Kopeloff,et al.  RECURRENT CONVULSIVE SEIZURES IN ANIMALS PRODUCED IMMUNOLOGIC AND CHEMICAL MEANS , 1942 .